Buchumschlag

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	William L. Baker, Alexandre Chan
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Assessment of Artificial Intelligence ( AI )‐Powered Self‐Care Recommendations for Management of Minor Ailments: A Comparative Analysis
von: Sham ZainAlAbdin, et al.
Veröffentlicht: (2025)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
von: Youjun Chen, et al.
Veröffentlicht: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
von: Amira R. Rashdan, et al.
Veröffentlicht: (2026)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
von: Keith A. Rodvold
Veröffentlicht: (2026)

Artificial Intelligence Large Language Model‐Influenced Bias on Trainees and Patients in Pharmacotherapeutic Decision Making
von: Andrew Chantha Hean, et al.
Veröffentlicht: (2026)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
von: Wenqiang Zhou, et al.
Veröffentlicht: (2026)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
von: Caroline Chen, et al.
Veröffentlicht: (2025)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
von: Sandra L. Kane‐Gill
Veröffentlicht: (2025)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
von: Eugene Jeong, et al.
Veröffentlicht: (2025)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
von: Jennifer N. Clements, et al.
Veröffentlicht: (2026)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
von: Amy Broadwater, et al.
Veröffentlicht: (2026)

Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review
von: Drew A. Wells, et al.
Veröffentlicht: (2026)

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
von: C. Michael White, et al.
Veröffentlicht: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
von: Maryam Aghakouchakzadeh, et al.
Veröffentlicht: (2026)

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
von: Zachary P. Brehm, et al.
Veröffentlicht: (2025)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
von: Adrian Valadez, et al.
Veröffentlicht: (2026)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
von: Alfred Zheng Ting Ho, et al.
Veröffentlicht: (2026)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
von: Yaping Zhan, et al.
Veröffentlicht: (2025)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
von: Iftekhar Ahmed, et al.
Veröffentlicht: (2026)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
von: Daniela Gorski, et al.
Veröffentlicht: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
von: Amanda Massmann, et al.
Veröffentlicht: (2025)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
von: Jyotirmoy Sarker, et al.
Veröffentlicht: (2024)

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
von: Saurabh Rahurkar, et al.
Veröffentlicht: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Veröffentlicht: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
von: Alexandre Duong, et al.
Veröffentlicht: (2024)

C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?
von: Nicoline Bihelek, et al.
Veröffentlicht: (2025)

Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization
von: Zhi‐Chun Gu, et al.
Veröffentlicht: (2024)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
von: Candice L. Garwood, et al.
Veröffentlicht: (2024)

Response to Comment on “Establishing discordance rate of estimated glomerular filtration rate between serum creatinine‐based calculations and cystatin‐C‐based calculations in critically ill patients”
von: Victoria L. Williams, et al.
Veröffentlicht: (2025)

Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink”
Veröffentlicht: (2024)

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
von: Ronald G. Hall, et al.
Veröffentlicht: (2025)

Chloride dipstick to rapidly estimate urine sodium during diuresis in acute heart failure
von: Vacha Shah, et al.
Veröffentlicht: (2025)

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin
von: Oluwadolapo D. Lawal, et al.
Veröffentlicht: (2025)

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns
von: Jay D. Olivet, et al.
Veröffentlicht: (2025)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
von: Casey L. Keller, et al.
Veröffentlicht: (2026)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
von: Lena Makortoff, et al.
Veröffentlicht: (2024)

Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study
von: Cornelis F. Vos, et al.
Veröffentlicht: (2024)

The Use of Plasma Exchange for Clozapine Intoxication: A Case Report
von: Bradley J. Peters, et al.
Veröffentlicht: (2025)

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
von: Erika L. Hellenbart, et al.
Veröffentlicht: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
von: Nicholas C. Tonial, et al.
Veröffentlicht: (2025)